Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Trihexyphenidyl Adverse Reaction: early-phase trial registry
1 of 1 indexed Trihexyphenidyl Adverse Reaction trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
Trihexyphenidyl Adverse Reaction: 1 US clinical trial tracked, 1 recruiting.
Trihexyphenidyl Adverse Reaction is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Mercy Hospital Kansas City, running 1 of these trials.
Enrollment posture brief
Registry condition trihexyphenidyl-adverse-reaction
OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Trihexyphenidyl Adverse Reaction lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Trihexyphenidyl Adverse Reaction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Trihexyphenidyl Adverse Reaction is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Trihexyphenidyl Adverse Reaction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Trihexyphenidyl Adverse Reaction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Trihexyphenidyl Adverse Reaction page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Trihexyphenidyl Adverse Reaction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Mercy Hospital Kansas City sponsors the most Trihexyphenidyl Adverse Reaction trials on record, review their full trial history before evaluating a specific study. See Children's Mercy Hospital Kansas City's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Trihexyphenidyl Adverse Reaction condition card totals 1 registered trials; most-linked intervention Trihexyphenidyl; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.